CVI are hosting the 2nd International Symposium on Immunotherapy in May 2015. Click here for details.
Welcome To The Cancer Vaccine Institute
The Cancer Vaccine Institute (CVI) funds research into the use of vaccines for the treatment of cancer. Our vision is that cancer vaccines will become a standard treatment and improve survival rates and patients’ quality of life for a wide range of cancers.
For regular updates from CVI, enter your email below.
Thank you for your interest in the Cancer Vaccine Institute. We have just released the Autumn 2014 newsletter, we hope you will enjoy reading about all our loyal and dedicated supporters and all the different ways in which they have been raising money for our pioneering research. Pleae click on the link above. Details of the new CVI Christmas card for 2014 - 'wrapped up reindeer', along with all the old favourites, can also be found on the newsletter as well on this website.
Following on from the huge success in 2013, we are busy organising the CVI's 2nd International Symposium on Immunotherapy for May 2015. Speakers from around the world will explore key areas of research into synergism between immunotherapy and standard treatments in oncology and will offer an unparalleled opportunity for the international research and clinical community to come together. We are very proud to be hosting this event again, and look forward to producing a report that can be understood by non-scientists! If you would like to see the report from the previous symposium please see the link above.
We are currently fundraising to run two trials and will post details on the website once we have reached our target and are able to proceed. If you would like to help with our fundraising, we’d love to hear from you so please email us or make a donation.
Immodulon are a company that are doing trials of early pancreatic cancer and previously treated colorectal cancer. If you are a patient with either of those diseases please look at the Immodulon website: http://www.immodulon.com/developmentplans.php for details of their clinical trials.
We are a small charity which has to work hard to raise the £600,000 needed each year to continue our research work. All our income comes from voluntary sources.
Content on this page requires a newer version of Adobe Flash Player.